Aduro Biotech, Inc. (ADRO)
SeekingAlphaJun 26, '18
Neon Therapeutics prices IPO in range at $16/share
Neon Therapeutics ( NTGN ) has priced its initial public offering at $16, in the middle of its marketed range, IPO IPO Boutique reports. More news on: Neon Therapeutics, Aduro Biotech, Advaxis Inc., Healthcare stocks news, IPOs, Read more …
SeekingAlphaJun 25, '18
Neon Therapeutics Looks To Tap Into An Exciting Area Of Cancer Therapy. What Are The Prospects?
Author's note: Subscribers to the Total Pharma Tracker received more insights and access to exclusive discussion on the prospects of Neon Therapeutics. In 2018, the biggest emerging story in cancer medicine that's just under the radar is the targeting of neoantigens. And the company…